Correlation Between Inozyme Pharma and Inhibikase Therapeutics
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Inhibikase Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Inhibikase Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Inhibikase Therapeutics, you can compare the effects of market volatilities on Inozyme Pharma and Inhibikase Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Inhibikase Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Inhibikase Therapeutics.
Diversification Opportunities for Inozyme Pharma and Inhibikase Therapeutics
-0.72 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Inozyme and Inhibikase is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Inhibikase Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibikase Therapeutics and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Inhibikase Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibikase Therapeutics has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Inhibikase Therapeutics go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Inhibikase Therapeutics
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Inhibikase Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Inozyme Pharma is 1.53 times less risky than Inhibikase Therapeutics. The stock trades about -0.1 of its potential returns per unit of risk. The Inhibikase Therapeutics is currently generating about 0.28 of returns per unit of risk over similar time horizon. If you would invest 236.00 in Inhibikase Therapeutics on September 15, 2024 and sell it today you would earn a total of 108.00 from holding Inhibikase Therapeutics or generate 45.76% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Inhibikase Therapeutics
Performance |
| Timeline |
| Inozyme Pharma |
| Inhibikase Therapeutics |
Inozyme Pharma and Inhibikase Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Inhibikase Therapeutics
The main advantage of trading using opposite Inozyme Pharma and Inhibikase Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Inhibikase Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibikase Therapeutics will offset losses from the drop in Inhibikase Therapeutics' long position.| Inozyme Pharma vs. Puma Biotechnology | Inozyme Pharma vs. Iovance Biotherapeutics | Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. Zentalis Pharmaceuticals Llc |
| Inhibikase Therapeutics vs. Puma Biotechnology | Inhibikase Therapeutics vs. Iovance Biotherapeutics | Inhibikase Therapeutics vs. Day One Biopharmaceuticals | Inhibikase Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |